Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v13-EN Version v3-EN
Language English English
Date Updated 2025-02-19 2024-08-22
Drug Identification Number 02402076 02402076
Brand name PIPERACILLIN AND TAZOBACTAM FOR INJECTION PIPERACILLIN AND TAZOBACTAM FOR INJECTION
Common or Proper name PIPERACILLIN AND TAZOBACTAM FOR INJECTION PIPERACILLIN AND TAZOBACTAM FOR INJECTION
Company Name AURO PHARMA INC AURO PHARMA INC
Ingredients TAZOBACTAM PIPERACILLIN TAZOBACTAM PIPERACILLIN
Strength(s) 0.375G 3G 0.375G 3G
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging sizes (GTIN) (See additional packaging sizes) (See additional packaging sizes)
Additional packaging sizes Vial Vial
ATC code J01CR J01CR
ATC description BETA-LACTAM ANTIBACTERIALS, PENICILLINS BETA-LACTAM ANTIBACTERIALS, PENICILLINS
Reason for shortage Other (Please describe in comments) Demand increase for the drug.
Anticipated start date
Actual start date 2024-08-21 2024-08-21
Estimated end date Unknown 2024-09-15
Actual end date 2025-02-18
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Please be informed PIPERACILLIN AND TAZOBACTAM FOR INJECTION is now available under Eugia label DIN: 02528703
Health Canada comments